Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Cardiovascular magnetic resonance for evaluation of cardiac involvement in COVID-19: recommendations by the Society for Cardiovascular Magnetic Resonance

[thumbnail of Publisher's version]
Preview
PDF (Publisher's version) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
1MB
[thumbnail of Supplementary Information] Other (Supplementary Information)
123kB

Item Type:Review
Title:Cardiovascular magnetic resonance for evaluation of cardiac involvement in COVID-19: recommendations by the Society for Cardiovascular Magnetic Resonance
Creators Name:Ferreira, V.M., Plein, S., Wong, T.C., Tao, Q., Raisi-Estabragh, Z., Jain, S.S., Han, Y., Ojha, V., Bluemke, D.A., Hanneman, K., Weinsaft, J., Vidula, M.K., Ntusi, N. A.B., Schulz-Menger, J. and Kim, J.
Abstract:Coronavirus disease 2019 (COVID-19) is an ongoing global pandemic that has affected nearly 600 million people to date across the world. While COVID-19 is primarily a respiratory illness, cardiac injury is also known to occur. Cardiovascular magnetic resonance (CMR) imaging is uniquely capable of characterizing myocardial tissue properties in-vivo, enabling insights into the pattern and degree of cardiac injury. The reported prevalence of myocardial involvement identified by CMR in the context of COVID-19 infection among previously hospitalized patients ranges from 26 to 60%. Variations in the reported prevalence of myocardial involvement may result from differing patient populations (e.g. differences in severity of illness) and the varying intervals between acute infection and CMR evaluation. Standardized methodologies in image acquisition, analysis, interpretation, and reporting of CMR abnormalities across would likely improve concordance between studies. This consensus document by the Society for Cardiovascular Magnetic Resonance (SCMR) provides recommendations on CMR imaging and reporting metrics towards the goal of improved standardization and uniform data acquisition and analytic approaches when performing CMR in patients with COVID-19 infection.
Keywords:Cardiovascular Magnetic Resonance, COVID-19, SARS-CoV-2, Cardiac Complications, Myocarditis, Myocardial Infarction, Microinfarctions, Thrombotic Complications, Multisystem Inflammatory Syndrome, Diagnostic Criteria
Source:Journal of Cardiovascular Magnetic Resonance
ISSN:1097-6647
Publisher:BioMed Central
Volume:25
Number:1
Page Range:21
Date:27 March 2023
Official Publication:https://doi.org/10.1186/s12968-023-00933-0
PubMed:View item in PubMed

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library